Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01092819 · ClinicalTrials.gov registry record
A Clinical Trial to Assess the Acute Safety and Functional Outcome and Recovery After STROKE: The FIRST Trial
A clinical trial, sponsored by Penumbra.
- Completed
- Registry status
- 150
- Enrollment target
NCT01092819: Completed study, sponsored by Penumbra.
NCT01092819 is a clinical trial that has completed, run by Penumbra. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01092819 has completed, sponsored by Penumbra.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
Current literature has only limited information on the natural history of acute ischemic stroke from large vessel occlusion in a stroke cohort who presents within 8 hours from symptom onset, particularly on 90 day functional outcome as defined by the mRS. Data from this trial will advance our knowledge on this important topic and may serve as a bench mark for future trials
Interventions
- OTHER Current standard of care for acute ischemic stroke other than IV rtPA or other IA therapies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-12 |
What the finished NCT01092819 record still lists
NCT01092819 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Current standard of care for acute ischemic stroke other than IV rtPA or other IA therapies is the first listed.
NCT01092819 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01092819 about?
NCT01092819 is a clinical study titled "A Clinical Trial to Assess the Acute Safety and Functional Outcome and Recovery After STROKE: The FIRST Trial". Current literature has only limited information on the natural history of acute ischemic stroke from large vessel occlusion in a stroke cohort who presents within 8 hours from symptom onset, particularly on 90 day functional outcome as defined by the mRS. Data from this trial will advance our knowle...
What is the current status of trial NCT01092819?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2012-12. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01092819?
The interventions under investigation include: Current standard of care for acute ischemic stroke other than IV rtPA or other IA therapies (OTHER).
Who is sponsoring clinical trial NCT01092819?
This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia